Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00224_DB00541_nanopub.RAN_2V2lxE4O7UeKeLUx06H_hDvTtZaA8dSWtR78CAcvM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00224_DB00541 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00224_DB00541 label "DDI between Indinavir and Vincristine - Indinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Indinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00224_DB00541]" assertion.
- drugbank_resource:DB00224_DB00541 identifier "drugbank_resource:DB00224_DB00541" assertion.
- drugbank_resource:DB00224_DB00541 title "DDI between Indinavir and Vincristine - Indinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Indinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00541 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB00541 assertion.
- drugbank:DB00224 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB00541 assertion.